Funding for this research was provided by:
Received: 4 November 2021
Accepted: 5 July 2022
First Online: 10 July 2022
: The study was approved by the Institutional Review Board at Oregon Health & Science University. All participants provided informed consent prior to filling out the survey. All methods were performed in concordance with the Declaration of Helsinki.
: Not applicable.
: Dr. Rodriguez’s institution has received research funds from the National Institute of Health, the Robert Wood Johnson Foundation, and Merck for projects on which she is primary investigator. She has served as a contraceptive trainer for ACOG, Bayer, and Merck. All other authors do not have any possible conflicts of interest to disclose.